RE:BOTTOM LINE HEREcapebretongirl great post...If I may add, SZLS has one of the best sale pitch of all(saving money).
In this link under "clinical utility"
https://stagezerolifesciences.com/colonsentry-science.html Saving money...
(Quote) "Colonsentry can reduce healthcare cost by more than 20% through early intervention "(End Of Quote).
For a big Healthcare System or a big Insurance Network 20% saving is very, very big money (hundred of million a year).
Once SZLS sign one big Healthcare sytem other will be rushing to get on board just to save money.
Money is the most powerful incentive of all.
capebretongirl wrote: You know, sitting at .07 is a real downer after the high teens we enjoyed not all that long ago - the portfolio goes down big time and we are left scratching our heads on what went wrong. Until we look at some facts here to comprehend exactly where we are. Here they are:
1) After over a decade of R&D, clinical and preparatory work, we have arrived at the commercialization stage for colonsentry - a dream come true for any expanding company:
2) We are on the verge of generating real and substantial revenue for the first time ever in the history of this company - it will likely be shown in Q3 and grow thereafter - while the CEO optimistically called for 30 m, that will not happen but we should see some which will be a milestone:
3) We have a multi cancer detection giant named Aristotle in a clinical trial/validation stage which should receive FDA approval well ahead of competitors - simply because the clinical trial process for any new science can take up to ten years for approval. Our colon sentry FDA approved test will help support the Aristotle approval process as the blood reflection technology is similar.
4) We have for the first time ever, an independent marketing entity named Oncore to tell the world about our product and to secure contracts abroad. FDA equivalent approvals will be easier and quicker to obtain as the US integrity process is industry leading. Early indications are that they have met with success and ergo we should be hearing something soon in terms of contractual developments:
5) We have Coastal Medical under contract, along with TeleHealth and a multitude of clinics prepared to deliver our tests. More are being sought out as a means to spread word of mouth and further generate revenue:
6) We have a mysterious large Health Insurer collaboration which surely willl result in revenue for SZLS. We also have ongoing discussions with workplace employers, firefighters and others - these will be ongoing in order to secure future contracts and add to revenue:
7) We have a viable comparison to a successful $100 plus share company (CDN dollars) (EXAS) wherein our detection percentage is noticeably higher, test cost is considerably less, and the implementation process of testing is much more client friendly.
8) Our science is argueably situated in the #1 field of medical interest due to the high mortality rate cancer causes.
9) Finally, but factually, our sp just dropped to the panic low of .07 cents - WHY - because a bot sold to itself at days end to drop it yet another cent - a process that has been ongoing since the sp was at .17.
All this to say that we are not sitting on a junior mining company here hoping to strike a rich gold vein - rather we have already found that vein and it has been confirmed, we have obtained all mining permits (Colonsentry) and we are applying for more permits (Aristotle) to expand the find. Its now a matter finding buyers/partners to extract the riches. Sure the sp is scary but NOTHING of a negative nature has changed with this company - rather it has only ENHANCED its chances of becoming a huge success. Revenue talks, break even goals and then profitability are our goals and once this tiny company gets the one big break it deserves then we will arrive there quicker than anyone can imagine.
Please tell me where any of the aforementioned is inaccurate - it will be called pumping by the bashers, but for me it is a simple outline of where we are today and where we should be in the very near future. This is a dynamic company with no comparables, owning a science described as the holy grail by a credible and separate CEO (Stephan D). I will not be selling anytime soon - lets see where the sp is once some of the aforementined factors come to fruition!!